2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)Alexander R. Lyon, Julia Grapsa, Teresa López‐Fernández et al.|European Heart Journal|2022Cited by 2.7k
Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trialAlexandre Mebazaa, Gad Cotter, Beth A. Davison et al.|The Lancet|2022Cited by 1k
Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart FailureAlexandre Mebazaa, for the SURVIVE Investigators, Markku S. Nieminen et al.|JAMA|2007Cited by 987
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive CardiologyMarco Ambrosetti, Ann‐Dorthe Zwisler, Ana Abreu et al.|European Journal of Preventive Cardiology|2020Cited by 924
State of the Art: Using Natriuretic Peptide Levels in Clinical PracticeAlan S. Maisel, Eugene Braunwald, Christian Mueller et al.|European Journal of Heart Failure|2008Cited by 837